Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03727425
Other study ID # 18-BR-0001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date June 30, 2020

Study information

Verified date October 2020
Source Auris Health, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the feasibility of performing robotic navigation of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions will be evaluated.


Description:

Successful biopsy of peripheral pulmonary lesions remains a challenge due to a number of factors, one of which may be the ability to gain access to peripheral lesions due to the size and maneuverability of conventional bronchoscopes. In this study, the investigators will evaluate the feasibility of a new technique using a robotic endoscope with the Monarch navigational platform to both access and biopsy peripheral pulmonary lesions. The Monarch platform is a "robotic" assisted or electromechanical, software driven endoscopy system designed to be used by qualified physicians to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date June 30, 2020
Est. primary completion date September 12, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: 1. Capable and willing to give informed consent 2. Acceptable candidate for an elective, non-emergent bronchoscopic procedure 3. Solid peripheral lung lesions suspected of malignancy, between 1-5cm in size identified on thin slice CT scan within 14 days of the intended bronchoscopy procedure 4. Lack bleeding disorders Exclusion Criteria: 1. Medical contraindication to bronchoscopy 2. Patients with a subsolid nodule and/or ground-glass opacity lesions on pre-procedure chest CT 3. Patients with endobronchial involvement seen on chest CT 4. Lack fitness to undergo flexible bronchoscopy as determined by the bronchoscopist prior to procedure 5. Participation in any other investigational clinical trial (device or medication) 30 days before and throughout the duration of the study 6. Uncontrolled or irreversible coagulopathy 7. Female subjects who are pregnant or nursing or those of child-bearing potential refusing a pregnancy test 8. Have significant mediastinal lymphadenopathy on chest CT scan and/or PET CT abnormalities suggestive of advanced stage lung cancer with mediastinal lymph node involvement

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Robotic assisted bronchoscopy
Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.

Locations

Country Name City State
United States Medical University of South Carolina Charleston South Carolina
United States Cleveland Clinic Cleveland Ohio
United States Henry Ford Health System Detroit Michigan
United States Innova Fairfax Hospital Falls Church Virginia
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Auris Health, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Device or Procedure Related Adverse Events Computed as the number of patients with device or procedure related adverse events divided by number of patients who underwent the robotic bronchoscopy procedure. 24-84 hours post-procedure
Primary Successful Navigation to Targeted Peripheral Pulmonary Lesions Successful navigation is confirmed using radial probe endobronchial ultrasound (R-EBUS). the R-EBUS will be inserted into the working channel of the endoscope and advanced beyond the tip of the inner scope as the inner scope is advanced into the lung periphery towards the targeted lesion. As the endoscope is guided towards the targeted lesion, R-EBUS will confirm successful lesion localization prior to biopsies being performed. During the procedure, approximately 1 hour
Secondary Incidence of Complications Unrelated to Device Computed as the number of patients with events unrelated to device or procedure divided by number of patients who underwent the robotic bronchoscopy procedure. 24-84 hours post-procedure
Secondary Time to R-EBUS Confirmation (Lesion Localization) Defined by the time the robotic bronchoscope is inserted into the oropharynx until the localization of the targeted lesion is confirmed by REBUS. During the procedure, approximately 1 hour
Secondary Total Procedure Time Defined by the time the robotic bronchoscope is inserted into the oropharynx until the time a biopsy tool is removed. During the procedure
Secondary Diagnostic Yield Determined from the results of the bronchoscopy. Data was collected (as part of standard of care) through 1-year for calculation of diagnostic yield.
See also
  Status Clinical Trial Phase
Recruiting NCT04745962 - Thin EBUS Pilot Study
Completed NCT06033729 - Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA N/A
Withdrawn NCT05738031 - Investigating Incidental Pulmonary Nodules in Underserved Communities
Not yet recruiting NCT05716815 - Prospective rAndomized sTudy efficaCy tHree-dimensional rEconstructions Segmentectomy N/A
Completed NCT04758403 - CBCT-Guided Navigational Bronchoscopy For Lung Nodules N/A
Recruiting NCT04792632 - Clinical Performance Evaluation of Veye Lung Nodules
Recruiting NCT05801406 - From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection.
Recruiting NCT05426135 - Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Completed NCT04217655 - Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules N/A
Recruiting NCT05526573 - Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
Recruiting NCT04005677 - The Early Diagnosis of Pulmonary Nodule Based on Multi-dimension Messages
Active, not recruiting NCT04734145 - Using e-Nose Technology to Identify Early Lung Cancer
Enrolling by invitation NCT05183945 - Preoperative Computed Tomography-guided Localization for Lung Nodules: Localization Needle Versus Coil N/A
Recruiting NCT05665504 - Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
Not yet recruiting NCT04740606 - Airway Navigation Database Asia for Diagnosis of Peripheral Pulmonary Nodules
Recruiting NCT05306912 - Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules N/A
Recruiting NCT05463796 - InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Active, not recruiting NCT04885595 - Diagnosis of Peripheral Lung Nodules Using Cryobiopsy N/A